Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CAD Firms Solidify Mammography Deals, Look To Lung Indication

This article was originally published in The Gray Sheet

Executive Summary

R2 Technology and iCAD's agreements with imaging equipment players reflect a growing reliance on computer-aided detection for mammography screening

You may also be interested in...



CAD Increases Breast Cancer Detection, But Cannot Catch Them All

Computer-aided detection (CAD) can improve breast cancer detection on a mammogram by 7.4%, investigators report in the August issue of Radiology

CAD Increases Breast Cancer Detection, But Cannot Catch Them All

Computer-aided detection (CAD) can improve breast cancer detection on a mammogram by 7.4%, investigators report in the August issue of Radiology

R2 ImageChecker Approval Launches CAD Lung Market; iCAD Preps To Join

FDA approval of R2 Technology's ImageChecker CT CAD system for lung nodules July 8 provides the firm with a comfortable head-start over competitor iCAD, which expects to launch its own system in 2005

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT021365

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel